Physician profile
Safi Khan
NPI 1972979292
$9,326.48
in general payments reported to CMS, 2019-2025
23 companies · $1,215 in 2025
The $1,215 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.56 · 2022: $2,383 · 2023: $2,900 · 2024: $2,737 · 2025: $1,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,571 · Education: $272 · Travel and Lodging: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,571.32 |
| Education | $271.61 |
| Travel and Lodging | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,347.14 | 2021-2025 | Watchman Flx, Synergy, Avvigo Guidance System |
| Abbott Laboratories | $2,258.89 | 2021-2025 | Cardiomems, Dragonfly Opstar, Navitor |
| Medtronic, INC. | $1,883.31 | 2022-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Selectsecure |
| Amgen INC. | $579.45 | 2022-2025 | Repatha, Repatha |
| Abiomed | $443.30 | 2024-2025 | Impella |
| Philips North America LLC | $335.83 | 2023-2024 | (6342) Intrasight Integrated |
| Siemens Medical Solutions USA, INC. | $192.97 | 2022 | |
| Pfizer INC. | $184.30 | 2022-2023 | |
| Edwards Lifesciences Corporation | $172.32 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $150.47 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.42 | 2022-2024 | Jardiance |
| Biotronik INC. | $117.35 | 2022 | |
| Lantheus Medical Imaging, INC. | $103.87 | 2022-2024 | Definity |
| Actelion Pharmaceuticals US, INC. | $97.16 | 2022-2024 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $92.59 | 2022-2024 | Xarelto |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $68.33 | 2022-2023 | Gore Cardioform Septal Occluder |
| Ge Healthcare | $48.42 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $26.40 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.92 | 2022 | |
| Baxter Healthcare | $22.68 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $22.29 | 2025 | Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $18.28 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $16.79 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safi Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.